With the announcement of a-OS 4.0, Abstergo has been fielding a number of questions from the public, but the most common is why a company with a main focus on pharmaceutical development needs to explore the past in such great detail with the Animus.
Abstergo is committed to solving the toughest riddles in the medical community, with the most critical focus on eliminating antibiotic-resistant bacteria and super viruses. We know that rapid DNA mutations within these types of bacteria and viruses are what cause them to be resistant to pharmaceutical treatment, and that finding a way to stop these mutations from occurring will be the key to eliminating them. Our scientists believe that uncovering the source of a particular virus and tracking its progress throughout history will allow us to map its mutations and discover a pattern or common occurrence. By tracking more than one at a time, we can see if there is a similar pattern that spreads across all mutations. With the Animus, not only can we truly see history as it unfolds, but also retrieve accurate, first-hand data of the progress of human diseases.
Abstergo’s ultimate goal, however, is to develop a nanobot that can be administered to a patient orally in a pill. Once in the patient’s system, it will be able to identify, track, study, and destroy any infection from a common cold to cancer!
